GlassScriptPhysician profile
Fernando Ariza
NPI 1699750638
$1,681.28
in general payments reported to CMS, 2019-2025
15 companies · $299 in 2025
The $299 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $31.29 · 2022: $83.91 · 2023: $66.53 · 2024: $1,201 · 2025: $299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,325 · Travel and Lodging: $221 · Education: $20.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,324.58 |
| Travel and Lodging | $220.78 |
| Education | $20.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $573.94 | 2024 | Ellipsys Vascular Access System |
| Astrazeneca Pharmaceuticals LP | $278.51 | 2024-2025 | Lokelma, Farxiga, Fasenra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $180.94 | 2024 | Jardiance |
| Otsuka America Pharmaceutical, INC. | $89.38 | 2023-2024 | Jynarque |
| Calliditas Therapeutics US INC. | $76.97 | 2023-2025 | Tarpeyo |
| Fresenius USA Marketing, INC. | $70.56 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $67.86 | 2023-2025 | |
| Grifols USA, LLC | $65.53 | 2025 | Prolastin-C Liquid |
| Lilly USA, LLC | $64.05 | 2024-2025 | Jardiance |
| Regeneron Healthcare Solutions, INC. | $61.85 | 2025 | Dupixent |
| Vifor Pharma, INC. | $58.52 | 2022-2024 | Veltassa |
| Travere Therapeutics, INC. | $32.74 | 2024-2025 | Filspari |
| Glaxosmithkline, LLC. | $21.81 | 2024 | Benlysta |
| Ani Pharmaceuticals, INC. | $19.63 | 2025 | Purified Cortrophin Gel |
| Ardelyx, INC. | $18.99 | 2024 | Ibsrela |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fernando Ariza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.